Adaptimmune(ADAP)
搜索文档
Adaptimmune(ADAP) - 2021 Q4 - Earnings Call Transcript
2022-03-15 00:16
Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q4 2021 Earnings Conference Call March 14, 2022 8:30 AM ET Company Participants Juli Miller - Investor Relations Adrian Rawcliffe - Chief Executive Officer Dennis Williams - Senior Vice President, Late Stage Development Elliot Norry - Chief Medical Officer John Lunger - Chief Patient Supply Officer Helen Tayton-Martin - Chief Business Officer Karen Miller - Senior Vice President, Pipeline Research Gavin Wood - Chief Financial Officer Conference Call Participants Ma ...
Adaptimmune(ADAP) - 2021 Q3 - Earnings Call Transcript
2021-11-05 02:47
Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q3 2021 Earnings Conference Call November 4, 2021 8:00 AM ET Company Participants Juli Miller - IR Adrian Rawcliffe - CEO Elliot Norry - Senior VP and Chief Medical Officer John Lunger - Chief Patient Supply Officer Helen Tayton-Martin - Co-Founder and Chief Business Officer Conference Call Participants Marc Frahm - Cowen & Company Michael Schmidt - Guggenheim Nick Abbott - Wells Fargo Mara Goldstein - Mizuho Operator Good day, and thank you for standing by. Welcom ...
Adaptimmune(ADAP) - 2021 Q2 - Earnings Call Transcript
2021-08-10 10:44
Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q2 2021 Earnings Conference Call August 9, 2021 4:30 PM ET Company Participants Juli Miller - IR Adrian Rawcliffe - CEO Helen Tayton-Martin - Co-Founder and Chief Business Officer Elliot Norry - Senior VP and Chief Medical Officer John Lunger - Chief Patient Supply Officer Conference Call Participants Tony Butler - ROTH Capital Marc Frahm - Cowen and Company Kelsey Goodwin - Guggenheim Jonathan Chang - SVB Leerink Mara Goldstein - Mizuho Operator Good day and thank ...